Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Diabetes alters LDL receptor and PCSK9 expression in rat liver.

Authors: Niesen, M  Bedi, M  Lopez, D 
Citation: Niesen M, etal., Arch Biochem Biophys. 2008 Feb 15;470(2):111-5. Epub 2007 Nov 22.
Pubmed: (View Article at PubMed) PMID:18054320
DOI: Full-text: DOI:10.1016/

Since the hepatic LDL receptor is regarded as a major determinant of plasma LDL levels, the effect of diabetes on the expression of this receptor was examined in rat liver. Inducing diabetes with streptozotocin caused a significant reduction in hepatic LDL receptor mRNA levels in concert with an increase in serum cholesterol levels. However, LDL receptor protein levels were unaffected by the diabetic state. Further investigation revealed that protein levels of PCSK9, which has been shown to enhance the degradation of the LDL receptor protein, were significantly decreased in the diabetic rats explaining the lack of reduction in LDL receptor protein levels. These observations indicate that the rate of LDL receptor cycling (function) in diabetic rats is decreased resulting in higher serum LDL levels.


Disease Annotations
Objects Annotated

Additional Information

RGD Object Information
RGD ID: 2324626
Created: 2010-05-06
Species: All species
Last Modified: 2010-05-06
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.